- Home
- Articles
-
10.5606/tgkdc.dergisi.2012.063
Acute arterial thromboembolic treatment in an infant patient with nephrotic syndrome and antithrombin III deficiency
Ahmet Şaşmazel1, Ali Fedakar1, Ayşe Yıldırım2, Ayşe Baysal3, Mehmet Aksüt1, Kamil Boyacıoğlu1, Rahmi Zeybek1
1Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi, Kalp ve Damar Cerrahisi Kliniği, İstanbul, Türkiye
2Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi, Pediatrik Kardiyoloji Kliniği, İstanbul, Türkiye
3Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi, Anestezi ve Reanimasyon Kliniği, İstanbul, Türkiye
DOI : 10.5606/tgkdc.dergisi.2012.063
Antithrombin III (AT III) deficiency, a coagulation
disorder in nephrotic syndrome, which is characterized
by increased trombocyte reactivation and loss of urinary
protein, particularly leads to increased incidence of
thromboembolism. Although arterial thromboembolism
is rarely associated with nephrotic syndrome in children,
it is one of the leading causes of increased morbidity and
mortality. In this article, we present an 18-month-old boy
who was admitted to the Emergency Unit in our hospital
with acute onset of purple veins under the skin and pain
and lack of motion in the left lower limb and diagnosed
with AT III deficiency secondary to nephrotic syndrome.
The clinical examination revealed motor dysfunction and
necrotic tissue changes in the left lower limb. Acute arterial
thromboembolism was diagnosed. Clinical prognosis was
improved following medical and surgical treatments without
the need for amputation of the limb. In this report, the
administration of intraarterial tissue plasminogen activator
during surgical thromboembolectomy in children, dose and
side effects of the therapy and other treatment of choices
were discussed.
Keywords : Antithrombin III deficiency; arterial occlusive disease; nephrotic syndrome; thromboemboli
Viewed : 14178
Downloaded : 3266